Tesla rumored to be taking over this small lithium mining company

*Together with

Good day, 360 –

Here are our top 3 trade ideas today – these setups look primed! Be the best prepared trader on the Street!

SGML - Up 27% as Tesla said to be considering buying this small lithium miner, reports Bloomberg

TRKA - This MEME stock is up over 40% on no news

ATNM - 10% higher in pre-market after positive leukemia drug results

SGML - Up 27% as Tesla said to be considering buying this small lithium miner, reports Bloomberg

On Friday in after-hours trade, Bloomberg reported (citing sources) that Tesla is considering buying Sigma Lithium Corp (SGML) causing the stock to trade over 25% in pre-market this morning. Elon Musk has been talking about Tesla mining its own lithium for numerous years now so this report may well have some legs. The potential deal is still just a rumor at this point.

The pre-market high for SGML is $39.99 and represents an all-time high for SGML. A takeover offer would likely be above all-time highs given that SGML has been one of the stronger stocks in the market over the last 12 months and thus any takeover should be at a significant premium.

$37 has so far been a pivot point in the pre-market. Above it targets to the upside are $38, $39 and $40.

Below it, there is potential support at $36, $35.33 and a gap to fill all the way to $29.48 if these rumors fail to have substance or the deal falls through.

TRKA - This MEME stock is up over 40% on no news

Troika Media Group (TRKA) had no news but was one of the top Reddit short squeeze mentions on Friday. With a short float of just under 20% according to Finviz, TRKA is a MEME favorite. The stock is down over 80% from its 2021 IPO price and is currently a penny stock. The Apes finally got a hold of this one so it is one to keep on your watchlist today especially if some stubborn shorts get trapped.

$0.39 was resistance in the pre-market and TRKA also failed there in the after-hours a couple of weeks back so that is the first major target for bulls.

Above $0.39, there is potential resistance at $0.45 and $0.50, with a gap to fill at $0.65.

The $0.30 area has acted as support in the pre-market so far and below that there is a gap to fill at $0.2201.

ATNM - 10% higher in pre-market after positive leukemia drug results

On Sunday, Actinium Pharmaceuticals (ATNM) announced positive full data results from its Phase 3 trial in patients with active, relapsed or refractory acute myeloid leukemia. The stock was up as high as 30% post the news this morning and is now around 10% higher.

In addition, HC Wainwright reiterated its Buy rating on ATNM and maintained its $53 price target representing over 200% upside from current levels.

There has been some support for ATNM in the pre-market at the $15 area so that should be an important pivot level this morning. The $15 area was a major resistance level from back in November.

Above it, targets to the upside are $17, and then the pre-market high of $18 with $19 and $20 above that.

Below $15, there is a gap to fill at $13.76 with potential support at $12 and then $11 below that.

Economic Calendar (EST)

9:45am PMI Composite

10:00am Existing Home Sales 

No Fed Speakers Scheduled

Earnings for Today (After Market)

ABCL, AGR, AHT, AINV, ALIT, APLE, AROC, ATRC, BCC, BKD, BSM, BXC, CHK, COIN, CSGP, CSR, CVI, CW, CWAN, CWH, CZR, EQX, ESI, EXAS, FANG, FLS, GFL, GMED, GTE, HALO, HCKT, HY, IAA, ICCC, IOSP, IVR, JBGS, KAR, KEYS, KW, LAND, LEU, LPI, LZB, MATX, MED, MTDR, NHI, O, PANW, PEB, PET, PSA, PTCT, PUMP, QTWO, QUAD, RBA, RIG, SAND, SBAC, SBRA, SKT, SPT, STAA, TALK, TOL, TWNK, UAN, UNVR, VLRS, VNOM, VRE, WK, WSC, WTTR, XPER, ZIP

Top Headlines

HLX: Helix Announces $200 Million Share Repurchase Program

MNOV: MediciNova Announces New Data Regarding MN-166 (ibudilast) in Glioblastoma Tumor Tissue Analysis Presented at the 20th Annual World Congress of Society for Brain Mapping and Therapeutics

RNAZ: Closing of $1.5 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules

TSLA: US NHTSA Reaches Out To Tesla About Fatal Crash In California - Driver Died After Colliding With Fire Truck In Bay Area : Tesla driver killed after barreling into ladder truck blocking accident scene on California freeway -- California Highway Patrol officials did not immediately known if the driver was impaired or if the car was in Autopilot mode -- Fox

UBER: announced a partnership with Tata Motors to bring 25,000 new EVs onto Uber’s platform in India

LXRX: New Analyses of Sotagliflozin to Be Presented at the American College of Cardiology’s 72nd Annual Scientific Session Together with World Heart Federation’s World Congress of Cardiology

AMZN: Amazon Corporate Workers Face Pay Reduction After Shares Slip – WSJ

TSLA: Tesla is poised to unveil a cheaper ‘Model 2’ as other manufacturers struggle to turn a profit from the electric vehicle revolution -- The Times UK

HUGE: FSD Pharma Presenting Two Scientific Posters on Preclinical Toxicology and Efficacy Data of Lucid-21-302 (Lucid-MS) at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2023 Forum

MYNZ: Mainz Biomed Acquires Entire Intellectual Property Portfolio for its Colorectal Cancer Diagnostic Test Program

AFMD: AbCheck Announces Collaboration to Apply Microfluidics Technology to the Discovery of Antibodies Against Challenging Therapeutic Neurology Target

META: Tencent in Talks to Sell Meta’s Quest 2 VR Headset in China The deal could be a boon for Meta in China, where Facebook has been blocked since 2009 WSJ

NIO: China's Nio to build factory for budget EVs – Reuters

CRNT: Ceragon Launches AI-Based Intelligence and Management Software Suite for Multi-Vendor Wireless Transport Networks

VALN: FDA Accepts Valneva’s Chikungunya Vaccine BLA for Priority Review. PDUFA end of August

GOOG: U.S. Supreme Court mulls challenge to internet firms' legal shield

TECK: announces $250M share repurchase plan

TECK: Teck Resources to separate into two publicly-listed companies

MAXR: to provide environmental monitoring for Government of Guyana

AULT: Ault Alliance Announces the Addition of Data Center Services Veteran, Jay Looney, as the Chief Executive Officer of its Wholly-Owned Subsidiary, AC Management, Inc.

AKBA: Akebia Therapeutics Received Interim Response from the FDA to Appeal for Vadadustat for the Treatment of Anemia due to Chronic Kidney Disease

CNTG: In the Lead-Up to Rare Disease Day, CENTOGENE Expands Observational Study to Advance the Genetic Understanding of Frontotemporal Dementia (FTD)

MRK: Phase 3 move-ahead Trial Evaluating LAGEVRIO (molnupiravir) for Post-exposure Prophylaxis for Prevention of COVID-19

MRK: Merck to Present New Data for Sotatercept and MK-0616 at ACC.23/WCC, Demonstrating Significant Progress in Advancing Its Innovative Cardiovascular Pipeline

PFE: U.S. FDA Accepts Biologics License Application for Pfizer’s Respiratory Syncytial Virus Maternal Vaccine Candidate for Priority Review

NETI: Eneti Inc. Announces A Contract Award for Seajacks

BDX: BD Onclarity™ HPV Assay Receives FDA Approval for Use with Both BD SurePath™ Liquid-based Pap Test and Hologic ThinPrep® Pap Test

FWBI: First Wave BioPharma Announces Phase 2 Adrulipase Combination Trial Data to be Presented at the 2023 Digestive Disease Week (DDW) Conference

EVOK: Evoke Pharma and EVERSANA Selected to Present Results of Real-World Healthcare Utilization Study Comparing GIMOTI® and Oral Metoclopramide at the Digestive Disease Week Plenary Session

CGC: CANOPY GROWTH ANNOUNCES US$150 MILLION REGISTERED DIRECT OFFERING

DPRO: Draganfly to Showcase its Drone and AI Technology at the World Police Summit in Dubai

To Your Success!

Questions or concerns about our products? Email [email protected] © Copyright 2022, RagingBull - Refund Policy - Privacy Policy - Terms & Conditions